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Preliminary joint X-ray and neutron protein
crystallographic studies of ecDHFR complexed with
folate and NADP+
A crystal of Escherichia coli dihydrofolate reductase (ecDHFR) complexed with
folate and NADP+ of 4  1.3  0.7 mm (3.6 mm3) in size was obtained by
sequential application of microseeding and macroseeding. A neutron diffraction
data set was collected to 2.0 Å resolution using the IMAGINE diffractometer at
the High Flux Isotope Reactor within Oak Ridge National Laboratory. A 1.6 Å
resolution X-ray data set was also collected from a smaller crystal at room
temperature. The neutron and X-ray data were used together for joint
refinement of the ecDHFR–folate–NADP+ ternary-complex structure in order
to examine the protonation state, protein dynamics and solvent structure of the
complex, furthering understanding of the catalytic mechanism.
1. Introduction
Dihydrofolate reductase (DHFR) is an NADPH-dependent enzyme
that catalyzes the reduction of 7,8-dihydrofolate (DHF) to 5,6,7,8tetrahydrofolate (THF), which is required in the biosynthesis of
purine, thymine and several amino acids (Sawaya & Kraut, 1997;
Reyes et al., 1995; Chen et al., 1994). In rapidly proliferating cells,
DNA synthesis greatly increases the demand for dNTPs. THF is the
one-carbon carrier during dNTP synthesis. Hence, DHFR is a drug
target for cancer, malaria and rheumatoid arthritis to inhibit cell
proliferation (Yuthavong et al., 2012; Sharma & Chauhan, 2012;
Schweitzer et al., 1990).
During reduction of DHF, a proton is donated to the N5 atom of
the DHF pterin ring with a hydride transfer occurring from the
nicotinamide ring of NADPH to the C6 atom of DHF. Previously,
several catalytic mechanisms have been proposed based on experimental and theoretical studies of DHFR (Shrimpton & Allemann,
2002; Cummins & Gready, 2001; Falzone et al., 1994; Chen et al., 1994;
Bajorath et al., 1991). Most of these mechanisms involve a proton
relay that includes the catalytic Asp27, a structurally conserved water
molecule and the O4 atom of the pterin ring, which may tautomerize
from the keto to the enol form during catalysis. Some mechanisms
invoke a second water molecule to be directly involved in the
protonation of the N5 atom (Chen et al., 1994; Shrimpton & Allemann, 2002). Cummins & Gready (2001) have proposed that hydride
transfer from the nicotinamide C4 atom of NADPH to the C6 atom
of DHF occurs synchronously with the protonation of N5 to convert
DHF to THF (Cummins & Gready, 2001). It is generally proposed
that the deprotonated Asp27 is particularly important for the
increase in the value of pKa of the N5 atom of the substrate from 2.4
to 6.5 (Khavrutskii et al., 2007; Chen et al., 1994; Bajorath et al., 1991;
Maharaj et al., 1990; Fig. 1). The ability to differentiate between the
mechanisms proposed above is limited because the protonation states
of the ligand and catalytic residues are difficult to determine using
X-ray crystallography even at atomic resolution (Fisher et al., 2012).
Neutron crystallography (NC) can be used to locate H atoms and
can readily provide information on the protonation states of aminoacid residues and ligands, the identity of solvent molecules and the
nature of bonds involving hydrogen (Niimura & Bau, 2008; Blakeley
et al., 2008; Niimura, 1999). In addition, NC can also be used to study
protein dynamics by analyzing the backbone amide hydrogen/
deuterium-exchange (HDX) pattern: higher exchange rates have
been correlated to higher dynamics (Sukumar et al., 2010; Bennett et
Used by permission
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Figure 1
A proposed mechanism of dihydrofolate (DHF) reduction. The N5 atom of folate might be directly protonated by a neighboring water molecule. Another proposed
mechanism involves a proton relay from the catalytic Asp27 to a water molecule and the tautomerized O4 atom of DHF. Hydride transfer occurs from NADPH to the C6 of
DHF to convert DHF to tetrahydrofolate (THF).

al., 2006, 2008). To understand the catalytic mechanism of DHFR, it is
imperative to visualize both H atoms and protein dynamics. Therefore, H atoms, which are normally invisible in X-ray crystal structures
of DHFR, should become visible in neutron structures.
Here, we report the crystallization of Escherichia coli DHFR
(ecDHFR) in complex with folate and NADP+. As folate is a slowturnover substrate and NADP+ is inactive, the ecDHFR–folate–
NADP+ complex has been considered to be a pseudo-Michaelis
complex useful for the understanding of the catalytic mechanism of
DHFR (Falzone et al., 1994; Reyes et al., 1995; Sawaya & Kraut, 1997;
Bhabha et al., 2011). We obtained a 3.6 mm3 (4  1.3  0.7 mm)
crystal by optimizing the de novo crystallization conditions, followed
by microseeding and macroseeding techniques. A 2.0 Å resolution
neutron data set was collected with 79.3% completeness on the
IMAGINE beamline (Meilleur et al., 2013) located at the High Flux
Isotope Reactor (HFIR) within Oak Ridge National Laboratory, Oak
Ridge, Tennessee, USA. A 1.6 Å resolution room-temperature X-ray
data set was also collected from a smaller crystal harvested from the
same crystallization condition. Both data sets were used for joint
X-ray/neutron (XN) refinement (Afonine et al., 2010) to study the
reaction mechanism of DHFR.

to ecDHFR at a molar ratio of 3:1 when the protein was at only
1 mg ml1 (Sawaya & Kraut, 1997). After concentration to
30 mg ml1, NADP+ was added to the protein solution at a molar
ratio of 3:1 and the protein was further concentrated to 40 mg ml1.
The solution of the concentrated protein complex (ecDHFR–folate–
NADP+) was clarified at 15 000g for 45 min, aliquoted and stored at
80 C.
2.2. Crystallization

The ecDHFR–folate–NADP+ complex was crystallized de novo
using the hanging-drop method at 4 C: 1 ml protein solution was
added to 1 ml reservoir solution (18% PEG 400, 100 mM MnCl2,
20 mM imidazole pH 7.0). Crystals appeared in 1 d and continued to
grow for 5 d until they reached their largest dimensions. Although the
crystallization condition was optimized, most of the crystals were still
not single and formed dense clusters (Fig. 3a). Hence, the micro-

2. Materials and methods
2.1. Protein expression and purification

E. coli DHFR (ecDHFR) was cloned, expressed and purified using
the previously described protocol for the recombinant production of
Bacillus anthracis DHFR (Bennett et al., 2007). Briefly, the cDNA
of ecDHFR was cloned into a pET-SUMO vector (Invitrogen) with
SUMO and a 6His tag at the exact N-terminus of the construct. The
advantage of this fusion protein system is that, after cleavage, no
exogenous residues are left on the target protein. After expression in
competent E. coli BL21(DE3) cells, the protein was extracted using
sonication and centrifugation. The His-tagged protein was purified
via immobilized metal-affinity chromatography (IMAC) using a
nickel column. Next, the SUMO protease from yeast, Ulp1, was
added to the purified fusion protein to remove SUMO and the His
tag. The protease-treated protein mixture was loaded onto a new
nickel-affinity column and the flowthrough contained the pure wildtype ecDHFR (Fig. 2). Because of its poor solubility, folate was added
Acta Cryst. (2014). F70, 814–818

Figure 2
Purification of ecDHFR. After two-step purification using IMAC, ecDHFR can be
obtained with more than 90% purity. Lane 1, protein markers (labeled in kDa).
Lane 2, fusion protein from the first step of purification. Lane 3, Ulp1 proteasetreated protein mixture. Lane 4, wild-type ecDHFR after the second purification.
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seeding technique (Bergfors, 2003) was applied to obtain single
crystals using a cat whisker in the following condition: 15%(v/v) PEG
400, 100 mM MnCl2, 20 mM imidazole pH 7.0. The size of these
resultant crystals was usually 1.5  0.1  0.2 mm (0.03 mm3;
Fig. 3b), which is too small for neutron diffraction (Blakeley et al.,
2008; Bennett et al., 2005). To obtain a crystal of >1 mm3 in size and to
reduce the data-collection time, the macroseeding technique (Berg-

Table 1
Data collection and processing.
Values in parentheses are for the highest resolution shell.
Data collection

Neutron

X-ray

Space group
Unit-cell parameters (Å,  )

P212121
a = 34.3, b = 45.7, c = 98.9,
 =  =  = 90
2.0
8745
7.5 (5.8)
79.3 (61.3)
0.188 (0.305)
5.3 (3.2)

a = 34.3, b = 45.6, c = 99.0,
 =  =  = 90
1.6
20795
4.1 (4.0)
97.7 (94.0)
0.097 (0.446)
13.7 (2.97)

Resolution (Å)
Unique reflections
Multiplicity
Completeness (%)
Rmerge†
hI/(I)i

P P
P P
† Rmerge = hkl i jIi ðhklÞ  hIðhklÞij= hkl i Ii ðhklÞ, where Ii(hkl) is the measured
intensity and hI(hkl)i is the mean intensity of all measured observations of reflection
hkl.

fors, 2003) was applied. A small single crystal was picked from the
original crystallization drop and transferred to 2 ml washing solution
[20%(v/v) PEG 400, 100 mM MnCl2, 20 mM imidazole pH 7.0]. After
four consecutive rounds of washing using the washing solution, the
crystal was transferred into a large-volume crystallization drop [30 ml
protein solution (40 mg ml1) was added to 30 ml reservoir solution as
a sitting drop], which was pre-equilibrated against 1000 ml reservoir
solution (15% PEG 400, 100 mM MnCl2, 20 mM imidazole pH 7.0)
overnight at 4 C. This crystal continued to grow and reached a final
size of 4  1.3  0.7 mm (3.6 mm3) in one month (Fig. 3c).

2.3. Data collection and processing

Figure 3
Crystallization of the ecDHFR–folate–NADP+ complex. (a) De novo crystallization using the hanging-drop method. (b) Single crystals obtained using the
microseeding technique. (c) The 4  1.3  0.7 mm (3.6 mm3) size crystal obtained
from the macroseeding technique.
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The large crystal was mounted in a quartz capillary containing the
same reservoir solution listed above except it was formulated in 100%
D2O (Fig. 4a). The labile H atoms were allowed to exchange with D
by vapor diffusion for several weeks before starting data collection.
Quasi-Laue neutron diffraction data were collected to 2.0 Å resolution at room temperature on the IMAGINE beamline (Meilleur et al.,
2013) located at HFIR (Oak Ridge National Laboratory, Oak Ridge,
Tennessee, USA; Fig. 4b). The crystal was held stationary at a
different ’ setting for each exposure. A total of 33 images were
collected with an average exposure time of 12 h per image from four
different crystal orientations. The neutron data were processed using
LAUEGEN (Campbell, 1995), which was modified to account for the
cylindrical geometry of the detector (Campbell et al., 1998). LSCALE
(Arzt et al., 1999) was used to determine the wavelength-normalization
curve using the intensities of symmetry-equivalent reflections
measured at different wavelengths. No explicit absorption corrections
were applied. These data were then merged in SCALA, which is
incorporated in the CCP4 program suite (Winn et al., 2011). The
statistics of the neutron data collection are shown in Table 1.
A small crystal obtained using the microseeding technique and
appropriate for room-temperature X-ray diffraction was mounted
and equilibrated against the D2O-containing reservoir solution in the
same fashion as the crystal used for neutron diffraction. The 1.6 Å
resolution X-ray diffraction data were collected using a Rigaku
HomeFlux X-ray diffractometer equipped with a MicroMax-007 HF
X-ray generator, Osmic VariMax optics and an R-AXIS IV++ imageplate detector. The diffraction data were indexed, integrated and
scaled using the HKL-3000 software suite (Minor et al., 2006). The
statistics of X-ray data collection are shown in Table 1.
Acta Cryst. (2014). F70, 814–818
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Figure 4
Neutron data collection of the large ecDHFR crystal. (a) The crystal mounted in a quartz capillary. (b) A Laue neutron diffraction pattern of the crystal.

3. Results and discussion
Joint XN refinement (Adams et al., 2009) of the ternary-complex
structure is in progress utilizing PHENIX (Adams et al., 2010), which
allows the use of both the neutron and the X-ray data for complete
structural refinement (Afonine et al., 2010). The preliminary results
show that D atoms exchanged on the amide backbone and many side
chains were visible in the 2Fo  Fc and Fo  Fc nuclear density maps.
Owing to their incoherence and contribution to negative neutron
scattering, chemically non-exchangeable H atoms at aliphatic and
aromatic CH groups were detected as troughs in the 2Fo  Fc nuclear
density map. Some dynamic side chains of residues, such as Lys and
Arg, were not clear in the nuclear density map owing to the low data
completeness, but are clearly visible in the electron-density map
because of its higher resolution and data completeness. Detailed
structural analysis of the ternary complex will be reported elsewhere.
The reaction catalyzed by DHFR has been studied in depth over
the past 50 years using different spectroscopic, structural and theoretical methods. However, without direct observation of H atoms, the
mechanistic details still remain controversial. Here, we used NC to
study the structure of ecDHFR–folate–NADP+ ternary complex, a
pseudo model of the Michaelis complex. Elucidating the protonation
states of the ligands, key catalytic residues and solvent molecules
should be helpful to solve the longstanding puzzle.
To collect neutron diffraction data with reasonable resolution
(higher than 2.2 Å) for H-atom identification and within a reasonable
length of time, it is important to obtain a large crystal (>0.1 mm3), one
of the bottlenecks for NC (Blakeley et al., 2008). We first used the
microseeding technique to obtain small single crystals and then
applied the macroseeding technique to enhance the three-dimensional
growth of one crystal in a large volume of a pre-equilibrated crystallization drop. No other crystals appeared in the drop used for
macroseeding; thus, the protein in solution in the equilibrated drop
did not form new nucleations and was incorporated into the lattice
of the single transferred crystal. We found that during the crystal
transfer it is important to remove potential microcrystals by washing
the seed thoroughly. Otherwise, these invisible crystals attached to
the seed surface would become nuclei and consume free protein in
the crystallization drop that would grow into larger crystals, thus not
allowing the macroseed to grow to a large volume. As has been
detailed previously, we also found that it is important to slightly
decrease the precipitant concentration during seeding in order to
prevent the appearance of new crystals (Bergfors, 2003).
The flux on currently available neutron beamlines is considerably
lower than that of synchrotron X-ray beamlines or even in-house
X-ray diffractometers. Thus, the time required for data collection can
Acta Cryst. (2014). F70, 814–818

range from days to weeks (Niimura & Bau, 2008; Blakeley et al., 2008;
Bennett et al., 2008). In this work, we limited the data collection to
33 frames (12 h per frame) to keep the total data-collection time to
around two weeks (16.5 d). The overall data completeness is 79.3%
and the data completeness of the highest resolution shell is 61.3%
(Table 1). In this respect, the inclusion of the X-ray diffraction data
(data completeness of 97.7 and 94.0% overall and for the highest
resolution shell, respectively) in structure refinement was helpful for
increasing the data-to-parameter ratio and also for improving the
accuracy of the final model (Adams et al., 2009; Table 1). Combined
with the previous computational, structural and biophysical studies,
we expect that the XN refined structure will provide new understanding of the reaction mechanism of DHFR.
This work was partly supported by the Center for Structural
Molecular Biology supported by the US Office of Biological and
Environmental Research, US Department of Energy, under FWP
ERKP752. PL was partly supported by an NIH–NIGMS-funded
consortium (R01GM071939) between ORNL and LBNL to develop
computational tools for neutron protein crystallography. MAW is
supported by NIH grant R01GM092999. This research used facilities
sponsored by the Scientific User Facilities Division, Office of Basic
Energy Sciences, US Department of Energy. QW was partly
supported by grant 2013CXJ083 from Yangzhou University, China.
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